Bruce G. Allen Investments’s 10x Genomics TXG Stock Holding History

Bruce G. Allen Investments’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.4K	Hold	113	–	–	﹤0.01%	670
2025 Q4	$1.84K	Hold	113	–	–	﹤0.01%	710
2025 Q3	$1.32K	Hold	113	–	–	﹤0.01%	768
2025 Q2	$1.31K	Buy	113 +61	+117%	+$556	﹤0.01%	777
2025 Q1	$454	Buy	+52	New	+$656	﹤0.01%	962
2024 Q4	–	Sell	-49	Closed	-$1.11K	–	1146
2024 Q3	$1.11K	Sell	49 -114	-70%	-$2.36K	﹤0.01%	802
2024 Q2	$3.17K	Buy	163 +137	+527%	+$3.59K	﹤0.01%	626
2024 Q1	$976	Hold	26	–	–	﹤0.01%	783
2023 Q4	$1.46K	Buy	+26	New	+$1.13K	﹤0.01%	792

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bruce G. Allen Investments's TXG Position: Q1 2026 in Review

Bruce G. Allen Investments held its 10x Genomics (TXG) position steady in Q1 2026 at 113 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Bruce G. Allen Investments first reported a position in TXG in Q4 2023 and has held it in 9 quarters since. The position peaked at $3.17K in Q2 2024. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Bruce G. Allen Investments held 113 shares of 10x Genomics worth $2.4K as of Q1 2026.
Bruce G. Allen Investments left its 10x Genomics share count unchanged in Q1 2026.
10x Genomics made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q1 2026, its #670 holding.
Bruce G. Allen Investments first reported a position in 10x Genomics in Q4 2023 and has held it in 9 quarters since.
Bruce G. Allen Investments's 10x Genomics position peaked at $3.17K in Q2 2024.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.